Prostate Cancer
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Conference Coverage
Plant-based diet linked to better outcomes in prostate cancer
Men who consumed more fruits and vegetables had slower cancer progression and lower risk of recurrence.
Conference Coverage
Prostate cancer subgroup may benefit from intensified therapy
A new trial explored whether for patients with prostate cancer who have unfavorable features and a detectable PSA following a radical...
Conference Coverage
Talazoparib add-on improves outcomes in metastatic prostate cancer
As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide monotherapy.
Conference Coverage
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
Conference Coverage
Colorectal cancer treatment outcomes in older adults
Disease-free survival boosted by adjuvant therapy completion, but only about half of patients finish.
Feature
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.
From the Journals
‘Low-value’ prostate cancer screening prevalent in primary care
A new study shows that testing for prostate-specific antigen and also digital rectal examinations are both carried out frequently in older men.
Conference Coverage
Most men with low-risk prostate tumors now forgoing treatment
Roughly 60% of men eligible for active surveillance chose that approach in 2021, up from 27% in 2014 and less than 10% in 2010.
From the Journals
Is it time to remove ‘cancer’ label from low-risk prostate tumors?
Experts argue that overtreatment could be reduced by removing the word “cancer” from low-risk disease.
Latest News
MRI far safer than CT for guiding radiotherapy in prostate cancer
MRI guidance more than halved the risk of genitourinary toxicities.